Martha G. Aronson is the President and Chief Executive Officer of Merit Medical Systems, Inc., a global leader in medical device manufacturing and distribution focused on cardiology, radiology, and endoscopy solutions. With over 25 years of experience in the healthcare industry, Aronson began her career as a biomedical engineer at Boston Scientific, where she advanced through roles in product development and regulatory affairs. She later served as Vice President of Global Operations at Medtronic, overseeing the integration of key acquisitions and driving operational efficiencies that boosted profitability by 35% during her tenure. Aronson's leadership has been marked by transformative achievements, including spearheading Merit Medical's expansion into emerging markets and launching innovative product lines such as advanced hemostasis devices and vascular access systems. Under her guidance since joining the company in 2018 as Chief Operating Officer, Merit Medical achieved record revenues exceeding $1.2 billion in 2023, alongside strategic partnerships with major healthcare providers. Her commitment to innovation earned her the Medical Device CEO of the Year award from MedTech Europe in 2022, recognizing her efforts in advancing minimally invasive technologies. As CEO, Aronson steers Merit Medical's vision toward sustainable growth and patient-centered innovation, emphasizing diversity in leadership and ESG initiatives. She holds a Bachelor of Science in Biomedical Engineering from MIT and an MBA from Harvard Business School, and serves on the boards of the Advanced Medical Technology Association (AdvaMed) and several nonprofit health organizations.